Abich Financial Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
FP
Abich Financial Wealth Management's MRNA Position: Q3 2024 in Review
Abich Financial Wealth Management increased its Moderna (MRNA) stake by 278% in Q3 2024, buying an estimated $5.88K and bringing the position to 87 shares worth $5.81K. The position accounts for 0.01% of the portfolio, ranked #245.
Abich Financial Wealth Management first reported a position in MRNA in Q1 2024 and has held it in 3 quarters since. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.
- Abich Financial Wealth Management held 87 shares of Moderna worth $5.81K as of Q3 2024.
- Abich Financial Wealth Management bought 64 Moderna shares in Q3 2024, an estimated $5.88K.
- Moderna made up 0.01% of Abich Financial Wealth Management's portfolio in Q3 2024, its #245 holding.
- Abich Financial Wealth Management first reported a position in Moderna in Q1 2024 and has held it in 3 quarters since.
- 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.
Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.